Literature DB >> 28886945

Cost of a measles outbreak in a remote island economy: 2014 Federated States of Micronesia measles outbreak.

Jamison Pike1, Ashley Tippins2, Mawuli Nyaku3, Maribeth Eckert2, Louisa Helgenberger4, J Michael Underwood2.   

Abstract

After 20years with no reported measles cases, on May 15, 2014 the Centers for Disease Control and Prevention (CDC) was notified of two cases testing positive for measles-specific immunoglobulin M (IgM) antibodies in the Federated States of Micronesia (FSM). Under the Compact of Free Association, FSM receives immunization funding and technical support from the United States (US) domestic vaccination program managed by the Centers for Disease Control and Prevention (CDC). In a collaborative effort, public health officials and volunteers from FSM and the US government worked to respond and contain the measles outbreak through an emergency mass vaccination campaign, contact tracing, and other outbreak investigation activities. Contributions were also made by United Nations Children's Emergency Fund (UNICEF) and World Health Organization (WHO). Total costs incurred as a result of the outbreak were nearly $4,000,000; approximately $10,000 per case. Direct medical costs (≈$141,000) were incurred in the treatment of those individuals infected, as well as lost productivity of the infected and informal caregivers (≈$250,000) and costs to contain the outbreak (≈$3.5 million). We assessed the economic burden of the 2014 measles outbreak to FSM, as well as the economic responsibilities of the US. Although the US paid the majority of total costs of the outbreak (≈67%), examining each country's costs relative to their respective economy illustrates a far greater burden to FSM. We demonstrate that while FSM was heavily assisted by the US in responding to the 2014 Measles Outbreak, the outbreak significantly impacted their economy. FSM's economic burden from the outbreak is approximately equivalent to their entire 2016 Fiscal Year budget dedicated to education. Published by Elsevier Ltd.

Entities:  

Keywords:  Cost of outbreak; Economic burden; Federated States of Micronesia; Measles

Mesh:

Year:  2017        PMID: 28886945      PMCID: PMC5831405          DOI: 10.1016/j.vaccine.2017.08.075

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

Review 1.  Should outbreak response immunization be recommended for measles outbreaks in middle- and low-income countries? An update.

Authors:  K Lisa Cairns; Robert T Perry; Tove K Ryman; Robin K Nandy; Rebecca F Grais
Journal:  J Infect Dis       Date:  2011-07       Impact factor: 5.226

2.  Investigation of a measles outbreak in Cordillera, Northern Philippines, 2013.

Authors:  Paola Katrina Ching; Ma Justina Zapanta; Vikki Carr de Los Reyes; Enrique Tayag; Rio Magpantay
Journal:  Western Pac Surveill Response J       Date:  2016-07-11

3.  Measles Outbreak Associated with Vaccine Failure in Adults--Federated States of Micronesia, February-August 2014.

Authors:  Lucy Breakwell; Edna Moturi; Louisa Helgenberger; Sameer V Gopalani; Craig Hales; Eugene Lam; Umid Sharapov; Maribeth Larzelere; Eliaser Johnson; Carolee Masao; Eleanor Setik; Lisa Barrow; Samantha Dolan; Tai-Ho Chen; Minal Patel; Paul Rota; Carole Hickman; William Bellini; Jane Seward; Greg Wallace; Mark Papania
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-10-02       Impact factor: 17.586

4.  Health care-associated measles outbreak in the United States after an importation: challenges and economic impact.

Authors:  Sanny Y Chen; Shoana Anderson; Preeta K Kutty; Francelli Lugo; Michelle McDonald; Paul A Rota; Ismael R Ortega-Sanchez; Ken Komatsu; Gregory L Armstrong; Rebecca Sunenshine; Jane F Seward
Journal:  J Infect Dis       Date:  2011-04-28       Impact factor: 5.226

5.  Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Huong Q McLean; Amy Parker Fiebelkorn; Jonathan L Temte; Gregory S Wallace
Journal:  MMWR Recomm Rep       Date:  2013-06-14

Review 6.  Increasing Coverage of Appropriate Vaccinations: A Community Guide Systematic Economic Review.

Authors:  Verughese Jacob; Sajal K Chattopadhyay; David P Hopkins; Jennifer Murphy Morgan; Adesola A Pitan; John M Clymer
Journal:  Am J Prev Med       Date:  2016-02-01       Impact factor: 5.043

7.  Suboptimal measles-mumps-rubella vaccination coverage facilitates an imported measles outbreak in ireland.

Authors:  Suzie Coughlan; Jeff Connell; Bernard Cohen; Li Jin; William W Hall
Journal:  Clin Infect Dis       Date:  2002-06-06       Impact factor: 9.079

Review 8.  Measles - The epidemiology of elimination.

Authors:  David N Durrheim; Natasha S Crowcroft; Peter M Strebel
Journal:  Vaccine       Date:  2014-11-04       Impact factor: 3.641

9.  Assessment of Climate-sensitive Infectious Diseases in the Federated States of Micronesia.

Authors:  Lachlan McIver; Masahiro Hashizume; Ho Kim; Yasushi Honda; Moses Pretrick; Steven Iddings; Boris Pavlin
Journal:  Trop Med Health       Date:  2014-11-15

10.  Measles Outbreak Associated With Low Vaccine Effectiveness Among Adults in Pohnpei State, Federated States of Micronesia, 2014.

Authors:  Craig M Hales; Eliaser Johnson; Louisa Helgenberger; Mark J Papania; Maribeth Larzelere; Sameer V Gopalani; Emmaculate Lebo; Greg Wallace; Edna Moturi; Carole J Hickman; Paul A Rota; Hinden S Alexander; Mona Marin
Journal:  Open Forum Infect Dis       Date:  2016-03-24       Impact factor: 3.835

View more
  2 in total

1.  The economic burden of measles in children under five in Bangladesh.

Authors:  Gatien de Broucker; Sayem Ahmed; Md Zahid Hasan; Gazi Golam Mehdi; Jorge Martin Del Campo; Md Wazed Ali; Md Jasim Uddin; Dagna Constenla; Bryan Patenaude
Journal:  BMC Health Serv Res       Date:  2020-11-10       Impact factor: 2.655

Review 2.  Cost of Nine Pediatric Infectious Illnesses in Low- and Middle-Income Countries: A Systematic Review of Cost-of-Illness Studies.

Authors:  Gatien de Broucker; So Yoon Sim; Logan Brenzel; Margaret Gross; Bryan Patenaude; Dagna O Constenla
Journal:  Pharmacoeconomics       Date:  2020-10       Impact factor: 4.981

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.